Rare diseases
Investigational molecules
Locations
Study of Nucresiran in Adults with Transthyretin Amyloidosis with Cardiomyopathy to Evaluate its Effects on Survival and Heart Problems
FranceStudy of ficerafusp alfa and pembrolizumab as first treatment for patients with PD-L1-positive recurrent or metastatic head and neck cancer
FranceStudy of felzartamab compared to placebo in adults with IgA nephropathy
FranceStudy of ivonescimab with chemotherapy combination for first and second-line treatment in patients with advanced or metastatic gastric and gastroesophageal cancer
FranceStudy of immunosuppression reduction in kidney transplant patients with septic shock or respiratory failure receiving drug combination therapy in intensive care
FranceStudy of baricitinib versus placebo for treating polymyalgia rheumatica in adult patients
FranceStudy comparing RMC-6236 and docetaxel in previously treated patients with advanced or metastatic non-small cell lung cancer who have RAS mutations
FranceComparing rifampin-free treatment versus rifampin in adults with staphylococcal prosthetic valve endocarditis
FranceStudy of sonrotoclax plus obinutuzumab or rituximab compared to venetoclax plus rituximab in patients with relapsed or refractory chronic lymphocytic leukemia
FranceStudy of Port Delivery System with ranibizumab given every 36 weeks in patients with neovascular age-related macular degeneration
FranceStudy of datopotamab deruxtecan with platinum-based therapy compared to gemcitabine with platinum-based therapy in patients with advanced urothelial cancer after prior treatment
FranceEarly Treatment with Argipressin (Arginine Vasopressin) in Adult Intensive Care Patients with Norepinephrine-Resistant Vasoplegic Shock
FranceTell us about your condition – we search every trial in Europe and connect you with the right site.
